⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Maya RankovaM.D.

Internal Medicine · Far Rockaway, NY 11691

NPI: 1881772044

Share:

33

🟠 Elevated

Risk Flags

High cost outlier (population + peer)High long-acting opioid rate vs peersHigh antipsychotic prescribing (65+)Extreme fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

14,841

Total Claims

$2.9M

Drug Cost

299

Beneficiaries

$9,687

Cost/Patient

Risk Score Breakdown 33/100

Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
Long-acting opioid rate+8
Cost per patient outlier+6
High fills per patient+5

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

-87%

Opioid rate vs peers

0.3% vs 2.2% avg

+587%

Cost per patient vs peers

$9,687 vs $1,411 avg

+169%

Brand preference vs peers

28.6% vs 10.6% avg

🔎 Data Overview

💰

Cost per patient is 587% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

0.3%

Opioid Rate

43

Opioid Claims

$572

Opioid Cost

27.9%

Long-Acting Rate

Brand vs Generic

71% generic

Brand: 4,131 claims · $2.5M

Generic: 10,336 claims · $349K

Patient Profile

76

Avg Age

66%

Female

1.87

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About